GLP-1R

CAT # Product Name Tsanangudzo
CPD100594 TT15 TT15 inyanzvi yeGLP-1R.
CPD100593 VU0453379 VU0453379 ndeye CNS-inopinda glucagon-yakaita peptide 1 receptor (GLP-1R) yakanaka allosteric modulator (PAM)
CPD100592 PF-06882961 PF-06882961 ine simba, nemuromo bioavailable agonist yeglucagon-like peptide-1 receptor (GLP-1R).
CPD100591 PF-06372222 PF-06372222 idiki-morekuru negative allosteric modulator (NAM) yeglucagon receptor (GCGR). Vanopikisa GCGR vanogona kubatsira mukurapa rudzi rwechipiri chirwere cheshuga mellitus nokuti vanogadzirisa mazinga eglucose yeplasma nekuderedza kana kuderedza kugadzirwa kweglucose yeropa nekuisa chiratidzo muchiropa, mumatumbo akatsetseka mhasuru, itsvo, uropi, uye adipose tishu. PF-06372222 inopikisawo glucagon-like peptide-1 receptor GLP-1R, iyo inhibits glucagon secretion uye glucose-inotsamira insulin secretion uye inogonawo kuita basa mukuburitswa kwemahomoni kunotungamira kuacute uye kusingaperi kushushikana uye kusagadzikana. Nekukanganisa modulating GLP-1R, PF-06372222 inogona kurapa rudzi rwechipiri chirwere cheshuga mellitus uye kushushikana uye kusagadzikana.
CPD100590 NNC0640 NNC0640 is negative allosteric modulator yeglucagon-like peptide-1 receptor (GLP-1R).
CPD100589 HTL26119 HTL26119 inova allosteric antagonist yeglucagon-like peptide-1 receptor (GLP-1R).
...

Taura nesu

Inquiry

Latest News

  • Pamusoro 7 Trends MuKutsvaga Kwemishonga Muna 2018

    Epamusoro 7 Mafambiro Mukutsvakurudza Kwemishonga Ini...

    Kuve pasi pekumanikidzwa kunoramba kuchiwedzera kukwikwidza munzvimbo yakaoma yehupfumi uye tekinoroji, makambani emishonga uye ebiotech anofanirwa kuramba achivandudza muzvirongwa zvavo zveR&D kuti varambe vari mberi ...

  • ARS-1620: Inovimbisa inhibitor itsva yeKRAS-mutant cancers

    ARS-1620: Inhibitor itsva inovimbisa yeK...

    Zvinoenderana neongororo yakaburitswa muSero, vaongorori vakagadzira chaiyo inhibitor yeKRASG12C inonzi ARS-1602 iyo yakakonzera kudzoka kwebundu mumakonzo. "Chidzidzo ichi chinopa in vivo humbowo hwekuti mutant KRAS inogona ...

  • AstraZeneca inogamuchira kukwidziridzwa kwemishonga yeoncology

    AstraZeneca inogamuchira kukwidziridzwa kwe ...

    AstraZeneca yakagamuchira kukwidziridzwa kwakapetwa kaviri kweiyo oncology portfolio neChipiri, mushure mekunge US neEuropean regulators vabvuma kutumirwa kwemishonga yavo, danho rekutanga rekuhwina mvumo yemishonga iyi. ...

WhatsApp Online Chat !